SCHEMBL526053

SCHEMBL526053

O=[N+]([O-])c1ccccc1S(=O)(=O)NCCOc1cccc(C(O)O)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.51
KMT2A Q03164 3/20 0.49
MEN1 O00255 2/20 0.49
CYP19A1 P11511 2/20 0.46
HTT P42858 1/20 0.45
NPY5R Q15761 3/20 0.45
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
MMP1 P03956 1/20 0.44
MMP2 P08253 1/20 0.44
MMP9 P14780 1/20 0.44
MMP8 P22894 1/20 0.44
MMP13 P45452 1/20 0.44
LMNA P02545 1/20 0.42
MDM4 O15151 1/20 0.42
NFKBIA P25963 1/20 0.42
OPRK1 P41145 1/20 0.42
MDM2 Q00987 1/20 0.42
RELA Q04206 1/20 0.42
SLC40A1 Q9NP59 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL525997 0.80 ALDH1A1 (0.53) ALDH1A1KMT2AMEN1CYP19A1HTT
SCHEMBL5636629 0.76 KMT2A (0.64) ALDH1A1KMT2AMEN1CYP19A1HTT
SCHEMBL38654855 0.75 KMT2A (0.67) ALDH1A1KMT2AMEN1CYP19A1HTT
SCHEMBL525996 0.74 KMT2A (0.51) ALDH1A1KMT2AMEN1CYP19A1HTT
SCHEMBL30649118 0.74 KMT2A (0.71) ALDH1A1KMT2AMEN1CYP19A1HTT
SCHEMBL4389696 0.74 KMT2A (0.71) ALDH1A1KMT2AMEN1CYP19A1HTT
SCHEMBL2360330 0.74 KMT2A (0.61) ALDH1A1KMT2AMEN1CYP19A1HTT
SCHEMBL3546124 0.74 ALDH1A1 (0.67) ALDH1A1KMT2AMEN1CYP19A1HTT
SCHEMBL2747531 0.73 KMT2A (0.64) ALDH1A1KMT2AMEN1CYP19A1HTT
SCHEMBL38655017 0.72 KMT2A (0.56) ALDH1A1KMT2AMEN1CYP19A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598507-A1 ANTICANCER DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2013-06-05 EP disclosed
WO-2012014147-A1 ANTICANCER DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2012-02-02 WO disclosed